238 related articles for article (PubMed ID: 26768519)
1. Granulomatous skin involvement in a patient with an unusual NOD2 mutation.
Kuye IO; Adisa M; Nazarian RM; Arvikar SL; Smith GP
Australas J Dermatol; 2017 May; 58(2):142-144. PubMed ID: 26768519
[TBL] [Abstract][Full Text] [Related]
2. A Novel NOD2-associated Mutation and Variant Blau Syndrome: Phenotype and Molecular Analysis.
Ebrahimiadib N; Samra KA; Domina AM; Stiles ER; Ewer R; Bocian CP; Foster CS
Ocul Immunol Inflamm; 2018; 26(1):57-64. PubMed ID: 27419275
[TBL] [Abstract][Full Text] [Related]
3. Blau syndrome with a rare mutation in exon 9 of
Velickovic J; Silan F; Bir FD; Silan C; Albuz B; Ozdemir O
Autoimmunity; 2019; 52(7-8):256-263. PubMed ID: 31556326
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
Okazaki F; Wakiguchi H; Korenaga Y; Nakamura T; Yasudo H; Uchi S; Yanai R; Asano N; Hoshii Y; Tanabe T; Izawa K; Honda Y; Nishikomori R; Uchida K; Eishi Y; Ohga S; Hasegawa S
Pediatr Rheumatol Online J; 2021 Feb; 19(1):18. PubMed ID: 33602264
[TBL] [Abstract][Full Text] [Related]
5. Blau syndrome with NOD2 mutation in a 54-year-old man: A case report.
Wang Z; Yang M; Zhang Q; Zhang S; Sui H; Liu J; Yang Q
Int J Rheum Dis; 2023 Oct; 26(10):2080-2084. PubMed ID: 37246600
[TBL] [Abstract][Full Text] [Related]
6. A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?
Inoue Y; Kawaguchi Y; Shimojo N; Yamaguchi K; Morita Y; Nakano T; Arima T; Tomiita M; Kohno Y
Mod Rheumatol; 2013 Jul; 23(4):837-9. PubMed ID: 22821420
[TBL] [Abstract][Full Text] [Related]
7. Blau Syndrome: A Systemic Granulomatous Disease of Cutaneous Onset and Phenotypic Complexity.
Rose CD
Pediatr Dermatol; 2017 Mar; 34(2):216-218. PubMed ID: 27874205
[No Abstract] [Full Text] [Related]
8. Lipogranulomatous subconjunctival nodules: a novel presentation in Blau syndrome.
Ahmad M; Hermanson ME; Enzenauer R; Palestine A; Lin C; Meeks N; McCourt E
J AAPOS; 2017 Jun; 21(3):249-251. PubMed ID: 28532706
[TBL] [Abstract][Full Text] [Related]
9. A Novel Pathogenic
Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.
Mensa-Vilaro A; Cham WT; Tang SP; Lim SC; González-Roca E; Ruiz-Ortiz E; Ariffin R; Yagüe J; Aróstegui JI
Arthritis Rheumatol; 2016 Apr; 68(4):1039-44. PubMed ID: 26606664
[TBL] [Abstract][Full Text] [Related]
11. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).
Carreño E; Guly CM; Chilov M; Hinchcliffe A; Arostegui JI; Lee RW; Dick AD; Ramanan AV
Acta Ophthalmol; 2015 May; 93(3):253-7. PubMed ID: 25209167
[TBL] [Abstract][Full Text] [Related]
12. A Case of Blau Syndrome with NOD2 E383K Mutation.
Harada J; Nakajima T; Kanazawa N
Pediatr Dermatol; 2016 Nov; 33(6):e385-e387. PubMed ID: 27339507
[TBL] [Abstract][Full Text] [Related]
13. A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome.
Jain L; Gupta N; Reddy MM; Mittal R; Barik MR; Panigrahi B; Monie T; Basu S
Ocul Immunol Inflamm; 2018; 26(2):292-294. PubMed ID: 27625029
[TBL] [Abstract][Full Text] [Related]
14. Blau Syndrome With Delayed Cutaneous Manifestations: A Case Report.
Panah E; Garfield E; Zahirsha Z; Muhlbauer A; Lake E; Speiser J
Am J Dermatopathol; 2024 Jun; 46(6):381-382. PubMed ID: 38648024
[TBL] [Abstract][Full Text] [Related]
15. Blau Syndrome: Report of a Rare Entity with Congenital Ostium Secundum Atrial Septal Defect in a 7-year-old Chinese Girl.
Yang XH; Lin L; Sun JF; Jiang YQ
Acta Derm Venereol; 2019 Sep; 99(10):923-924. PubMed ID: 31120540
[No Abstract] [Full Text] [Related]
16. Familial Blau syndrome without uveitis caused by a novel mutation in the nucleotide-binding oligomerization domain-containing protein 2 gene with good response to infliximab.
Toral-López J; González-Huerta LM; Martín-Del Campo M; Messina-Baas O; Cuevas-Covarrubias SA
Pediatr Dermatol; 2018 May; 35(3):e180-e183. PubMed ID: 29570830
[TBL] [Abstract][Full Text] [Related]
17. Familial Blau syndrome:First molecularly confirmed report from India.
Janarthanan M; Poddar C; Sudharshan S; Seabra L; Crow YJ
Indian J Ophthalmol; 2019 Jan; 67(1):165-167. PubMed ID: 30574935
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members.
Milman N; Ursin K; Rødevand E; Nielsen FC; Hansen TV
Scand J Rheumatol; 2009; 38(3):190-7. PubMed ID: 19169908
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Jensen ME; Harrell K; McBride JD
Front Immunol; 2023; 14():1279329. PubMed ID: 37868966
[TBL] [Abstract][Full Text] [Related]
20. Blau syndrome with pulmonary nodule in a child.
Su J; Liu D
Australas J Dermatol; 2021 May; 62(2):217-220. PubMed ID: 33742458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
